Showing results (71-80 of 211) with videos related to
Sort By:
Pageof 22
Pharmaceutics|October 27, 2022
Comparative Analysis of Free-Circulating and Vesicle-Associated Plasma microRNAs of Healthy Controls and Early-Stage Lung Cancer PatientsLuigi Pasini, Ivan Vannini, Paola Ulivi, et al.Journal of Thoracic Disease|September 4, 2018
What information could the main actors of liquid biopsy provide? -a representative case of non-small cell lung cancer (NSCLC)Aldo Pezzuto, Mariangela Manicone, Maria Chiara Scaini, et al.International Journal of Environmental Research and Public Health|May 28, 2022
Motherhood in Alternative Detention Conditions: A Preliminary Case-Control StudyCarlo Lai, Linda Elisabetta Rossi, Federica Scicchitano, et al.International Journal of Molecular Sciences|June 19, 2024
Pathogenesis of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Case Report and Review of the LiteratureChiara Gioia, Marino Paroli, Raffaella Izzo, et al.The Prostate|October 1, 2009
Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expressionFrancesco Fabbri, Giovanni Brigliadori, Silvia Carloni, et al.Cell Stress & Chaperones|December 2, 2010
Effects of glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cellsElisa Tramentozzi, Rita Zamarchi, Andrea Pagetta, et al.Rivista Di Psichiatria|February 11, 2015
[Evaluating the activity of the Italian Mental Health Services inpatient and residential facilities: the PRISM (Process Indicator System for Mental health) indicators]Angelo Picardi, Emanuele Tarolla, Giovanni de Girolamo, et al.Nitric Oxide : Biology and Chemistry|May 13, 2008
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cellsAnna Tesei, Wainer Zoli, Francesco Fabbri, et al.International Journal of Oncology|February 14, 2013
Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell linesToni Ibrahim, Chiara Liverani, Laura Mercatali, et al.Anti-Cancer Drugs|September 16, 2009
Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell linesIvan Vannini, Wainer Zoli, Francesco Fabbri, et al.Pageof 22